International Journal of Diabetes & Metabolic Disorders(IJDMD)
ISSN: 2475-5451 | DOI: 10.33140/IJDMD
Impact Factor: 1.23
Researchers and authors can directly submit their manuscript online through this link Online Manuscript Submission.
SGLT2 Inhibitors: A Promising New Tool in Cardiology
Abstract
K. El Moatamid, R. Ezzahraoui, N. Salmi and Mohamed Cherti
Sodium-glucose cotransporter 2 (SGLT2) inhibitors have emerged as a promising class of medications in the field of cardiology. Originally developed for the treatment of type 2 diabetes, these agents have shown significant cardiovascular benefits beyond their hypoglycemic effects. This review article aims to provide an overview of the mechanisms of action, clinical evidence, and potential applications of SGLT2 inhibitors in the management of cardiovascular diseases.